Smartphone-assisted optical quantification of d-penicillamine in human plasm sample using toluidine blue as efficient chromogenic probe: introducing a novel portable device toward therapeutic drug monitoring (TDM)
4 affiliations
- 1Nutrition Research Center, Tabriz University of Medical Sciences Tabriz Iran
- 2Food and Drug Safety Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences Tabriz Iran
- 3Pharmaceutical Analysis Research Center, Pharmaceutical Science Institute, Tabriz University of Medical Sciences Tabriz Iran
- 4Department of Nanotechnology, Faculty of Chemistry, Urmia University Urmia Iran
Abstract
d-Penicillamine (DPA) is a crucial pharmacological agent widely employed in the clinical management of Wilson's disease, rheumatoid arthritis, and heavy metal poisoning due to its potent metal-chelating properties. Given the narrow therapeutic index of DPA and the critical need for precise monitoring to avoid systemic toxicity, developing rapid, sensitive, and accessible analytical methods is highly demanded by clinicians. This study introduces a novel, cost-effective, and sensitive optical sensor for DPA quantification using Toluidine Blue (TB) as the efficient chromogenic probe. Using smartphone-based Digital Image Colorimetry (DIC) coupled with RGB analysis, DPA was measured in the linear concentration range of 0.25 µM to 10 mM in human plasma samples. A key innovation of this research is the implementation of Parafilm-based micro-pad (PF-µPAD) as a portable, hydrophobic sensing substrate for construction of portable optical sensor, which demonstrated exceptional analytical performance for the chemical interaction of analyte-optical probe (DPA-TB), thereby surpassing the accuracy of conventional vial-based colorimetric method. The underlying molecular interaction mechanism was rigorously validated through Zeta potential measurements revealed a substantial shift from +13.4 to −19.3 mV upon DPA interaction with TB, confirming the formation of stable TB-DPA complexes. Furthermore, the assay exhibited suitable selectivity toward DPA against a broad spectrum of amino acids and biological interferents, with dopamine being the only cross-reactive species observed. Finally, the practical utility of this portable sensing platform in human plasma samples, highlighting its strong potential for clinical diagnostics and Therapeutic Drug Monitoring (TDM).
Related
- Smartphone-Assisted Phenol–Sulfuric Acid Assay with ImageJ Analysis for Total Carbohydrate Quantification
- A novel foam-board-based plasmonic chemosensor towards specific recognition of formaldehyde and acetaldehyde using silver nanoprism reinforced by 1,10-phenanthroline and d-penicillamine: construction of a miniaturized optical device by 3D printer towards rapid pharmaceutical analysis.
- Introducing Chirality into Graphene Oxide Layers through a Facile Amino Acid-Based Covalent Functionalization
- Smartphone-based colorimetric glucose biosensor using peroxidase-like activity of bimetallic catalyst supported onto graphitic carbon nitride nanosheets
- Corrosion Prediction of AZ31 Mg Alloy Using Machine Learning and Digital Smartphone Images
BibTeX
@article{nami2026smartphoneassisted,
title = {{Smartphone-assisted optical quantification of d-penicillamine in human plasm sample using toluidine blue as efficient chromogenic probe: introducing a novel portable device toward therapeutic drug monitoring (TDM)}},
author = {Fatemeh Nami and Farnaz Bahavarnia and Mohammad Hasanzadeh and Nasrin Shadjou},
journal = {RSC advances},
year = {2026},
month = oct,
doi = {10.1039/d6ra07917b},
url = {https://europepmc.org/article/PMC/PMC13670040},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Smartphone-assisted optical quantification of d-penicillamine in human plasm sample using toluidine blue as efficient chromogenic probe: introducing a novel portable device toward therapeutic drug monitoring (TDM)
AU - Fatemeh Nami
AU - Farnaz Bahavarnia
AU - Mohammad Hasanzadeh
AU - Nasrin Shadjou
PY - 2026
DA - 2026/10/15
JO - RSC advances
DO - 10.1039/d6ra07917b
UR - https://europepmc.org/article/PMC/PMC13670040
AB - d-Penicillamine (DPA) is a crucial pharmacological agent widely employed in the clinical management of Wilson's disease, rheumatoid arthritis, and heavy metal poisoning due to its potent metal-chelating properties. Given the narrow therapeutic index of DPA and the critical need for precise monitoring to avoid systemic toxicity, developing rapid, sensitive, and accessible analytical methods is highly demanded by clinicians. This study introduces a novel, cost-effective, and sensitive optical sensor for DPA quantification using Toluidine Blue (TB) as the efficient chromogenic probe. Using smartphone-based Digital Image Colorimetry (DIC) coupled with RGB analysis, DPA was measured in the linear concentration range of 0.25 µM to 10 mM in human plasma samples. A key innovation of this research is the implementation of Parafilm-based micro-pad (PF-µPAD) as a portable, hydrophobic sensing substrate for construction of portable optical sensor, which demonstrated exceptional analytical performance for the chemical interaction of analyte-optical probe (DPA-TB), thereby surpassing the accuracy of conventional vial-based colorimetric method. The underlying molecular interaction mechanism was rigorously validated through Zeta potential measurements revealed a substantial shift from +13.4 to −19.3 mV upon DPA interaction with TB, confirming the formation of stable TB-DPA complexes. Furthermore, the assay exhibited suitable selectivity toward DPA against a broad spectrum of amino acids and biological interferents, with dopamine being the only cross-reactive species observed. Finally, the practical utility of this portable sensing platform in human plasma samples, highlighting its strong potential for clinical diagnostics and Therapeutic Drug Monitoring (TDM).
SN - 2046-2069
ER -